Industry Supported Education

Sanofi Deskside Series

Content Sponsored by Sanofi This Sanofi Deskside Series presentation discusses the impact of autologous hematopoietic cell transplantation (HCT) and quadruplet induction therapy compared to a triplet regimen in the CASSIOPEIA and GRIFFIN Trials in transplant-eligible patients with newly diagnosed multiple myeloma. Visit HCTconsult.com to learn more about why early consultation for autologous HCT is important…